$65.2 Million is the total value of Versant Venture Management, LLC's 8 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 20.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | $30,297,000 | -3.2% | 498,558 | 0.0% | 46.45% | +48.7% | |
| PASG | Passage Bio, Inc. | $11,705,000 | -23.9% | 4,959,769 | 0.0% | 17.94% | +16.9% | |
| GRTS | Gritstone Oncology, Inc. | $8,618,000 | -41.3% | 3,561,150 | 0.0% | 13.21% | -9.8% | |
| ADVM | Adverum Biotechnologies, Inc. | $6,082,000 | -8.4% | 5,068,233 | 0.0% | 9.32% | +40.7% | |
| Minerva Surgical Inc. | $3,933,000 | -47.8% | 1,673,700 | 0.0% | 6.03% | -19.8% | ||
| ALGS | Aligos Therapeutics, Inc. | $2,808,000 | -43.7% | 2,320,381 | 0.0% | 4.30% | -13.6% | |
| CBAY | CymaBay Therapeutics, Inc. | $1,604,000 | -5.1% | 543,753 | 0.0% | 2.46% | +45.7% | |
| CLVS | Clovis Oncology, Inc. | $183,000 | -11.2% | 101,855 | 0.0% | 0.28% | +36.4% | |
| AKRO | Exit | Akero Therapeutics, Inc. | $0 | – | -617,727 | -100.0% | -8.75% | – |
| CRNX | Exit | Crinetics Pharmaceuticals, Inc. | $0 | – | -410,360 | -100.0% | -8.99% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CymaBay Therapeutics, Inc. | 35 | Q2 2023 | 10.2% |
| Clovis Oncology, Inc. | 32 | Q3 2022 | 53.2% |
| CRISPR Therapeutics AG | 23 | Q3 2023 | 77.2% |
| Ocular Therapeutix, Inc. | 22 | Q4 2020 | 18.0% |
| Gritstone Oncology, Inc. | 18 | Q3 2023 | 25.4% |
| Achaogen, Inc. | 18 | Q1 2019 | 23.5% |
| Adverum Biotechnologies, Inc. | 15 | Q3 2023 | 21.0% |
| Second Sight Medical Products, Inc. | 15 | Q3 2020 | 9.0% |
| Audentes Therapeutics, Inc. | 13 | Q3 2019 | 39.6% |
| Aligos Therapeutics, Inc. | 12 | Q3 2023 | 15.7% |
View Versant Venture Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-08 |
| 13F-HR | 2023-11-03 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-11 |
| 144 | 2023-04-20 |
| 13F-HR | 2023-02-09 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-10 |
| 13F-HR | 2022-02-11 |
View Versant Venture Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.